Use of Blinatumomab for Relapse Therapy of B-Cell Precursor Acute Lymphoblastic Leukemia

被引：0
|
作者：
Pawinska-Wasikowska, K. [1 ,2 ]
Wyrobek, E. [2 ]
Klekawka, T. [1 ,2 ]
Luszawska-Kutrzeba, T. [2 ]
Garus, K. [2 ]
Pietrys, D. [2 ]
Zaniewska-Tekieli, A. [2 ]
Wieczorek, A. [1 ,2 ]
Balwierz, W. [1 ,2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Dept Pediat Oncol & Hematol, Inst Pediat, Krakow, Poland
[2] Childrens Univ Hosp Krakow, Dept Pediat Oncol & Hematol, Krakow, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2019年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V177 SIOP1
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [21] Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases
    Wang, Yi-Lun
    Chang, Tsung-Yen
    Wen, Yu-Chuan
    Yang, Shu-Ho
    Hsiao, Yi-Wen
    Chiu, Chia-Chi
    Chen, Yu-Chieh
    Hu, Ruei-Shan
    Chen, Shih-Hsiang
    Jaing, Tang-Her
    Hsiao, Chih-Cheng
    HEMATOLOGY REPORTS, 2024, 16 (02) : 347 - 353
  • [22] Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab
    Jabbour, Elias J.
    Kantarjian, Hagop M.
    Goekbuget, Nicola
    Shah, Bijal D.
    Chiaretti, Sabina
    Park, Jae H.
    Rijneveld, Anita W.
    Gore, Lia
    Fleming, Shaun
    Logan, Aaron C.
    Ribera, Josep M.
    Menne, Tobias F.
    Mezzi, Khalid
    Zaman, Faraz
    Velasco, Kelly
    Boissel, Nicolas
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [23] Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Dombret, Herve
    Stein, Anthony
    Bonifacio, Massimiliano
    Graux, Carlos
    Faul, Christoph
    Brueggemann, Monika
    Taylor, Kate
    Mergen, Noemi
    Reichle, Albrecht
    Horst, Heinz-August
    Havelange, Violaine
    Topp, Max S.
    Bargou, Ralf C.
    LEUKEMIA & LYMPHOMA, 2020, 61 (11) : 2665 - 2673
  • [24] Blinatumomab: A First-in-Class Bispecific T-Cell Engager for Precursor B-Cell Acute Lymphoblastic Leukemia
    Buie, Larry W.
    Pecoraro, Joshua J.
    Horvat, Troy Z.
    Daley, Ryan J.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (09) : 1057 - 1067
  • [25] Benefit-Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Stein, Anthony
    Franklin, Janet L.
    Chia, Victoria M.
    Arrindell, Deborah
    Kormany, William
    Wright, Jacqueline
    Parson, Mandy
    Amouzadeh, Hamid R.
    Choudhry, Jessica
    Joseph, Guiandre
    DRUG SAFETY, 2019, 42 (05) : 587 - 601
  • [26] Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Lia Gore
    Franco Locatelli
    Gerhard Zugmaier
    Rupert Handgretinger
    Maureen M. O’Brien
    Peter Bader
    Deepa Bhojwani
    Paul-Gerhardt Schlegel
    Catherine A. Tuglus
    Arend von Stackelberg
    Blood Cancer Journal, 8
  • [27] Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Gore, Lia
    Locatelli, Franco
    Zugmaier, Gerhard
    Handgretinger, Rupert
    O'Brien, Maureen M.
    Bader, Peter
    Bhojwani, Deepa
    Schlegel, Paul-Gerhardt
    Tuglus, Catherine A.
    von Stackelberg, Arend
    BLOOD CANCER JOURNAL, 2018, 8
  • [28] Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
    M S Topp
    M Stelljes
    G Zugmaier
    P Barnette
    L T Heffner
    T Trippett
    J Duell
    R C Bargou
    C Holland
    J E Benjamin
    M Klinger
    M R Litzow
    Leukemia, 2018, 32 : 562 - 565
  • [29] Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
    Topp, M. S.
    Stelljes, M.
    Zugmaier, G.
    Barnette, P.
    Heffner, L. T., Jr.
    Trippett, T.
    Duell, J.
    Bargou, R. C.
    Holland, C.
    Benjamin, J. E.
    Klinger, M.
    Litzow, M. R.
    LEUKEMIA, 2018, 32 (02) : 562 - 565
  • [30] Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia
    J. L. Fuster
    F. Bautista
    B. González
    J. M. Fernández
    S. Rives
    J. L. Dapena
    Clinical and Translational Oncology, 2021, 23 : 1963 - 1966
12345